Skip to content
OpenCapital
Get started

DexCom DXCM Free cash flow

Free cash flow at other companies

Cabot Corporation logo
Cabot CorporationCBT
$32M+3,100%
Warrior Met Coal logo
Warrior Met CoalHCC
-$91.86M-59.5%
Travel + Leisure logo
Travel + LeisureTNL
$19M-81.0%
Bioventus logo
BioventusBVS
$8.36M+141%
Dave, Inc. logo
Dave, Inc.DAVE
$82.01M+81.4%
MYR Group logo
MYR GroupMYRG
$68.62M-2.3%

Other financials

Income statement

See full
Revenue$1.2B+15.0%
Gross profit$750.3M+27.4%
Operating income$255.3M+90.9%
Net income$199.5M+89.3%
EPS (diluted)$0.51+88.9%

Balance sheet

See full
Cash & equivalents$1.1B+23.4%
Total debt$143.0M+2.2%
Total equity$3.0B+30.5%
Total assets$6.6B-1.8%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%

Valuation

See full
Market cap$25.99B-17.5%
Enterprise value$25.01B-17.9%
P/E27.9×-27.2×
P/S5.4×-1.9×

Profitability

See full
Gross margin61.5%+2.1pp
Operating margin21.4%+6.2pp
Net margin19.3%+6.4pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity35.6%+11.9pp
Debt / equity0×0.0×
Current ratio1.9×+0.4×

Where this comes from

Calculated from DexCom’s reported figures.

$525.6Mnet cash from operating−$76.6Mcapital expenditures=$449M

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's free cash flow?
DexCom (DXCM) reported free cash flow of $449M in Q1 2026.
How has DexCom's free cash flow changed year-over-year?
DexCom's free cash flow increased by 363.8% year-over-year, from $96.8M to $449M.
What is the long-term trend for DexCom's free cash flow?
Over 4 years (2021 to 2025), DexCom's free cash flow has grown at a 112.0% compound annual growth rate (CAGR), from $53.3M to $1.08B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.